<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36921943</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Physical and cognitive impairments in people suffering from long COVID: protocol for a longitudinal population-based cohort study.</ArticleTitle><Pagination><StartPage>e064054</StartPage><MedlinePgn>e064054</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e064054</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-064054</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Approximately 33% of people who contracted COVID-19 still experience symptoms 12 weeks after infection onset. This persistence of symptoms is now considered a syndrome itself called 'long COVID'. Evidence regarding long COVID and its cognitive and physical impacts is growing, but the literature is currently lacking objectively measured data to guide towards adapted healthcare trajectories. The objectives are to describe the physical and cognitive impairments experienced by individuals living with long COVID using self-reported and clinical objective measures, and to compare the evolution over time of the physical and cognitive state between adults living with long COVID (at least one physical or cognitive COVID-19 symptom for more than 12 weeks following infection; long COVID group), people who developed COVID-19 but did not experience persistent symptoms (short COVID group) and people who did not develop COVID-19 (control group).</AbstractText><AbstractText Label="METHODS AND ANALYSIS">In this longitudinal cohort study, 120 participants will be recruited in each group. Variables will be collected through three evaluation sessions over 6 months (baseline, 3&#x2009;months, 6&#x2009;months). Variables include self-administered questionnaires on health-related quality of life, comorbidity, sleep, pain, anxiety, depressive symptoms, fatigue and cognitive function, as well as objective measures of cognitive (attention, memory, executive functioning) and physical (grip strength, balance, gait speed, gait endurance, VO2, frailty) functions. Activity, heart rate and sleep will be monitored with a fitness tracker watch for 7&#x2009;days following evaluation sessions. Maximum-likelihood analyses of variance (ANOVAs) will be used to compare data at baseline between groups. Repeated measures ANOVAs will be used to compare the longitudinal performance variations across groups of the self-reported and clinical variables.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Ethics committees of the CIUSSS de la Capitale-Nationale and CIUSSS de l'Est-de-l'&#xce;le-de-Montr&#xe9;al approved the project. Results will be disseminated through clinical and community platforms as well as through peer-reviewed manuscripts and international conferences.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT05216536.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zahouani</LastName><ForeName>Imane</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-2392-054X</Identifier><AffiliationInfo><Affiliation>Hospital Maisonneuve-Rosemont Research Center, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desmeules</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Maisonneuve-Rosemont Research Center, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Rehabilitation, Faculty of Medicine, Universit&#xe9; de Montreal, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perreault</LastName><ForeName>Kadija</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Faculty of Medicine, Universit&#xe9; Laval, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campeau-Lecours</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Faculty of Science and Engineering, Universit&#xe9; Laval, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Best</LastName><ForeName>Krista</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Faculty of Medicine, Universit&#xe9; Laval, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaulieu-Bonneau</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Psychology, Faculty of Social Sciences, Universit&#xe9; Laval, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquette</LastName><ForeName>Jean-S&#xe9;bastien</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-9524-6761</Identifier><AffiliationInfo><Affiliation>VITAM - Research Centre on Sustainable Health, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Universit&#xe9; Laval, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire ARIMED, Groupe de m&#xe9;decine de famille du Nord de Lanaudi&#xe8;re, CISSS Lanaudi&#xe8;re, Saint-Charles-Borrom&#xe9;e, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deslauriers</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VITAM - Research Centre on Sustainable Health, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daigle</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drouin</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tittley</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>Marie-Andr&#xe9;e</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmam</LastName><ForeName>Imane</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Faculty of Medicine, Universit&#xe9; Laval, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouillard</LastName><ForeName>Sarah-Maude</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Patient partners, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepage</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Patient partners, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Jean-S&#xe9;bastien</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Faculty of Medicine, Universit&#xe9; Laval, Quebec, Quebec, Canada jean-sebastien.roy@fmed.ulaval.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Interdisciplinary Research in Rehabilitation and Social Integration, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05216536</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Musculoskeletal disorders</Keyword><Keyword MajorTopicYN="N">REHABILITATION MEDICINE</Keyword><Keyword MajorTopicYN="N">Respiratory infections</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36921943</ArticleId><ArticleId IdType="pmc">PMC10030285</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-064054</ArticleId><ArticleId IdType="pii">bmjopen-2022-064054</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard . WHO coronavirus (COVID-19) dashboard with vaccination data. 2022. Available: https://covid19.who.int/</Citation></Reference><Reference><Citation>News: up to one in three people who have had COVID-19 report long COVID symptoms | NIHR. n.d.
Available: www.nihr.ac.uk/news/up-to-one-in-three-people-who-have-had-covid-19-report-long-covid-symptoms/27979</Citation></Reference><Reference><Citation>Mahase E. Covid-19: what do we know about &#x201c;long covid&#x201d;? [Internet]. BMJ
2020;370:m2815. 10.1136/bmj.m2815
Available: https://www.bmj.com/content/370/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, et al. . Long COVID, a comprehensive systematic scoping review. Infection 2021;49:1163&#x2013;86. 10.1007/s15010-021-01666-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et al. . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun 2021;94:138&#x2013;47. 10.1016/j.bbi.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, et al. . Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect 2021;82:e1&#x2013;4. 10.1016/j.jinf.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Leviner S. Recognizing the clinical sequelae of COVID-19 in adults: COVID-19 long-haulers. J Nurse Pract 2021;17:946&#x2013;9. 10.1016/j.nurpra.2021.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.05.003</ArticleId><ArticleId IdType="pmc">PMC8103144</ArticleId><ArticleId IdType="pubmed">33976591</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr 2021;15:869&#x2013;75. 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade DT. Rehabilitation after COVID-19: an evidence-based approach. Clin Med (Lond) 2020;20:359&#x2013;65. 10.7861/clinmed.2020-0353</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0353</ArticleId><ArticleId IdType="pmc">PMC7385804</ArticleId><ArticleId IdType="pubmed">32518105</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento IJ, von Groote TC, O&#x2019;Math&#xfa;na DP, et al. . Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-cov-2) infection in humans: a systematic review and series of meta-analyses. PLoS One 2020;15:e0239235. 10.1371/journal.pone.0239235</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239235</ArticleId><ArticleId IdType="pmc">PMC7498028</ArticleId><ArticleId IdType="pubmed">32941548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, et al. . Long-COVID: an evolving problem with an extensive impact. S Afr Med J 2020;111:10&#x2013;2. 10.7196/SAMJ.2020.v111i11.15433</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v111i11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, et al. . COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin Nurs Res
2022;31:1390&#x2013;8. 10.1177/10547738221125632
Available: https://www.medrxiv.org/content/10.1101/2021.03.03.21252086v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021;4:e2111417. 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c; long haulers &#x201d; stump experts. JAMA 2020;324:1381&#x2013;3. 10.1001/jama.2020.17709</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, et al. . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax 2021;76:402&#x2013;4. 10.1136/thoraxjnl-2020-216308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Baricich A, Borg MB, Cuneo D, et al. . Midterm functional sequelae and implications in rehabilitation after COVID-19: a cross-sectional study. Eur J Phys Rehabil Med 2021;57:199&#x2013;207. 10.23736/S1973-9087.21.06699-5</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.21.06699-5</ArticleId><ArticleId IdType="pubmed">33565741</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | guidance | NICE. 2022. Available: www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Canada PHA of . Coronavirus disease (COVID-19): symptoms and treatment [Internet]. 2022. Available: www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/symptoms.html</Citation></Reference><Reference><Citation>Donn&#xe9;es COVID-19 par r&#xe9;gion sociosanitaire . INSPQ. 2022. Available: www.inspq.qc.ca/covid-19/donnees/par-region</Citation></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727&#x2013;36. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin PD, Harrold L, Ayers DC. Incorporating patient-reported outcomes in total joint arthroplasty registries: challenges and opportunities. Clin Orthop Relat Res 2013;471:3482&#x2013;8. 10.1007/s11999-013-3193-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-013-3193-2</ArticleId><ArticleId IdType="pmc">PMC3792256</ArticleId><ArticleId IdType="pubmed">23897504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Garin O, Dima AL, et al. . EuroQol (EQ-5D-5L) validity in assessing the quality of life in adults with asthma: cross-sectional study. J Med Internet Res 2019;21:e10178. 10.2196/10178</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10178</ArticleId><ArticleId IdType="pmc">PMC6364208</ArticleId><ArticleId IdType="pubmed">30672744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha O, Stucki G, Liang MH, et al. . The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156&#x2013;63. 10.1002/art.10993</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10993</ArticleId><ArticleId IdType="pubmed">12687505</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollayeva T, Thurairajah P, Burton K, et al. . The pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev 2016;25:52&#x2013;73. 10.1016/j.smrv.2015.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2015.01.009</ArticleId><ArticleId IdType="pubmed">26163057</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahid A, Wilkinson K, Marcu S, et al. . Pittsburgh sleep quality index (PSQI). In: Shahid A, Wilkinson K, Marcu S, et al.., eds. STOP, THAT and One Hundred Other Sleep Scales. New York, NY: Springer, 2022: 279&#x2013;83. 10.1007/978-1-4419-9893-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-9893-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller S, Bann CM, Dodd SL, et al. . Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004;20:309&#x2013;18. 10.1097/00002508-200409000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002508-200409000-00005</ArticleId><ArticleId IdType="pubmed">15322437</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Decker O, M&#xfc;ller S, et al. . Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care 2008;46:266&#x2013;74. 10.1097/MLR.0b013e318160d093</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318160d093</ArticleId><ArticleId IdType="pubmed">18388841</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, et al. . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092&#x2013;7. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606&#x2013;13. 10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Health Questionnaire . Physiopedia. 2022. Available: www.physio-pedia.com/Patient_Health_Questionnaire</Citation></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, et al. . The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121&#x2013;3. 10.1001/archneur.1989.00520460115022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatigue Severity Scale . Physiopedia. n.d.
Available: www.physio-pedia.com/Fatigue_Severity_Scale</Citation></Reference><Reference><Citation>Iverson GL, Marsh JM, Connors EJ, et al. . Normative reference values, reliability, and item-level symptom endorsement for the PROMIS&#xae; v2.0 cognitive function-short forms 4A, 6A and 8a. Arch Clin Neuropsychol 2021;36:1341&#x2013;9. 10.1093/arclin/acaa128</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acaa128</ArticleId><ArticleId IdType="pubmed">33454756</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcastle_post_Covid_Screening_Tool.pdf. 2022. Available: https://postcovidsyndromebsol.nhs.uk/images/Content/Newcastle_post_Covid_Screening_Tool.pdf</Citation></Reference><Reference><Citation>MoCA test. MoCA &#x2013; Cognitive Assessment; 2022. Available: www.mocatest.org/the-moca-test/</Citation></Reference><Reference><Citation>Freitas S, Sim&#xf5;es MR, Mar&#xf4;co J, et al. . Construct validity of the Montreal cognitive assessment (MoCA). J Int Neuropsychol Soc 2012;18:242&#x2013;50. 10.1017/S1355617711001573</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617711001573</ArticleId><ArticleId IdType="pubmed">22115097</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical assessment canada - english. 2022. Available: www.pearsonclinical.ca/</Citation></Reference><Reference><Citation>Reitan RM. Manual for administration of neuropsychological test batteries for adults and children. Tucson, AZ: Reitan Neuropsychology Laboratories, 1979.</Citation></Reference><Reference><Citation>Decomposition of the trail making test - reliability and validity of a computer assisted method for data collection | archives of assessment psychology. 2022. Available: www.assessmentpsychologyboard.org/journal/index.php/AAP/article/view/38</Citation></Reference><Reference><Citation>Trail making test - an overview | sciencedirect topics. 2022. Available: www.sciencedirect.com/topics/medicine-and-dentistry/trail-making-test</Citation></Reference><Reference><Citation>Bohannon RW. Grip strength: an indispensable biomarker for older adults. Clin Interv Aging 2019;14:1681&#x2013;91. 10.2147/CIA.S194543</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S194543</ArticleId><ArticleId IdType="pmc">PMC6778477</ArticleId><ArticleId IdType="pubmed">31631989</ArticleId></ArticleIdList></Reference><Reference><Citation>Guralnik JM, Ferrucci L, Simonsick EM, et al. . Lower-Extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556&#x2013;61. 10.1056/NEJM199503023320902</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199503023320902</ArticleId><ArticleId IdType="pmc">PMC9828188</ArticleId><ArticleId IdType="pubmed">7838189</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcuri JF, Borghi-Silva A, Labadessa IG, et al. . Validity and reliability of the 6-minute step test in healthy individuals: a cross-sectional study. Clin J Sport Med 2016;26:69&#x2013;75. 10.1097/JSM.0000000000000190</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JSM.0000000000000190</ArticleId><ArticleId IdType="pubmed">25706661</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: let patients help define long-lasting COVID symptoms. Nature 2020;586:170. 10.1038/d41586-020-02796-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Six minute walk test / 6 minute walk test - physiopedia. 2022. Available: www.physio-pedia.com/Six_Minute_Walk_Test_/_6_Minute_Walk_Test?utm_source=physiopedia&amp;utm_medium=related_articles&amp;utm_campaign=ongoing_internal</Citation></Reference><Reference><Citation>Compagnat M, Mandigout S, Batcho CS, et al. . Validity of wearable actimeter computation of total energy expenditure during walking in post-stroke individuals. Ann Phys Rehabil Med 2020;63:209&#x2013;15. 10.1016/j.rehab.2019.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2019.07.002</ArticleId><ArticleId IdType="pubmed">31408710</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical frailty scale. Specialised Clinical Frailty Network; 2022. Available: www.scfn.org.uk/clinical-frailty-scale</Citation></Reference><Reference><Citation>Evenson KR, Goto MM, Furberg RD. Systematic review of the validity and reliability of consumer-wearable activity trackers. Int J Behav Nutr Phys Act 2015;12:159. 10.1186/s12966-015-0314-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12966-015-0314-1</ArticleId><ArticleId IdType="pmc">PMC4683756</ArticleId><ArticleId IdType="pubmed">26684758</ArticleId></ArticleIdList></Reference><Reference><Citation>Evenson KR, Spade CL. Review of validity and reliability of garmin activity trackers. J Meas Phys Behav 2020;3:170&#x2013;85. 10.1123/jmpb.2019-0035</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/jmpb.2019-0035</ArticleId><ArticleId IdType="pmc">PMC7323940</ArticleId><ArticleId IdType="pubmed">32601613</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliason S. Maximum likelihood estimation. 2455 Teller Road, Newbury Park California 91320 United States of America: SAGE Publications, Inc.; 1993, 2022. 10.4135/9781412984928</Citation><ArticleIdList><ArticleId IdType="doi">10.4135/9781412984928</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>